Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata available, this FDA Warning Letter issued to Promise Pharmacy, LLC on July 29, 2019 concerns drug products and indicates regulatory compliance issues that warranted formal FDA action. While the specific violations are not detailed in the provided metadata, the warning was issued under FDA's drug regulatory authority. Without access to the complete letter text, the precise nature of the deficiencies cannot be determined, though typical pharmacy warnings involve manufacturing, quality control, or distribution practices.